Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ALPHAGAN P
- Brimonidine for Intraoperative Hemostasis
- Brimonidine Tartrate for Pterygium Surgery
- Comparison of Efficacy and Ocular Surface Disease Assessment Between BRIDIN-T Eye Drops 0.15% and ALPHAGAN-P Eye Drops 0.15% in Glaucoma or Ocular Hypertensive Patients : Phase 4, Parallel Group Design, Investigator-blind, Active-control, Randomized
- Brimonidine for Subconjunctival Hemorrhage From Femtosecond Laser Assisted Cataract Surgery
- The Effect of Brimonidine
- Pre-Administration of Brimonidine in Intravitreal Anti-VEGF Therapy
- Evaluation of Safety and Efficacy of Brimonidine Tartrate Ophthalmic Suspension
- Efficacy and Necessity of Time Interval Between Instillation of Two Glaucoma Eye Drops
- The Effect of Brimonidine on Intraocular Pressure When Dilating Routine Patients
- The Relationship Between Intraocular Pressure and Macular Edema in Patients With Diabetic Macular Edema
- The Effect of Topical Treatment With Combigan Compared to Timolol and Brimonidine on Pupil Diameter
- Effect of Antiglaucoma Agents on Short Term Intraocular Pressure Fluctuations After Intravitreal Bevacizumab Injection
- Transconjunctival Needling Revision Versus Medical Treatment
- A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension
- A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension
- Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
- Effect of Alphagan and Xalatan Eye Drops on Corneal Temperature
- Effect of Alphagan on Retinal Blood Flow Autoregulation and Motion Detection in Patients With Normal Pressure Glaucoma
- Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal Bevacizumab
- Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG)
- Comparison of Efficacy of Two Groups of Glaucoma Drops (Xalatan vs.Cosopt) in Reducing Eye Pressure Following Laser (SLT)Treatment in the Management of Glaucoma.
- Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes
- Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops
- Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost
- Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan
Clinical trials list
click for details